Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Administration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02984228
What this trial is testing

Platelet-rich Plasma vs. Hyaluronic Acid for Glenohumeral Osteoarthritis

Who this might be right for
OsteoarthritisShoulder Pain
Hospital for Special Surgery, New York 70
Not applicableStudy completedNCT01475409
What this trial is testing

A Study on Changes in IFN-gamma Levels Following Anti-TNF Treatment in Patients Undergoing Serial QuantiFERON-TB Gold In-Tube

Who this might be right for
Inflammatory Rheumatic Diseases
University of Roma La Sapienza 119
Not applicableStudy completedNCT03043638
What this trial is testing

Efficiency of PRP on Acellular Dermal Matrix Application in the Treatment of Multiple Adjacent Gingival Recessions

Who this might be right for
Gingival Recession, Generalized
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization 12
Post-approval studies (Phase 4)Study completedNCT00455585
What this trial is testing

Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products

Who this might be right for
HIV Infections
Makerere University 18
Not applicableNot Yet RecruitingNCT06882278
What this trial is testing

Pulsed Radiofrequency Combined With Platelet-Rich Plasma Applied to the Sphenopalatine Ganglion in Treating Episodic Cluster Headache

Who this might be right for
Cluster HeadachePain ManagementEpisodic Cluster Headache
Beijing Tiantan Hospital 242
Testing effectiveness (Phase 2)Study completedNCT02362035
What this trial is testing

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

Who this might be right for
Follicular Lymphoma (FL)CLLSmall Lymphocytic Lymphoma (SLL)+10 more
Acerta Pharma BV 161
Testing effectiveness (Phase 2)Study completedNCT01701076
What this trial is testing

Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Cantonal Hospital of St. Gallen 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07560449
What this trial is testing

QLS4131 Combination Therapy in Malignant Plasma Cell Neoplasms

Who this might be right for
Malignant Plasma Cell Neoplasms
Qilu Pharmaceutical Co., Ltd. 162
Early research (Phase 1)Study completedNCT00291538
What this trial is testing

Comparison of Pharmacokinetics and Pharmacodynamics of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Nantes University Hospital 20
Early research (Phase 1)Active Not RecruitingNCT05431608
What this trial is testing

MCARH109 and MCARH125 in People With Multiple Myeloma

Who this might be right for
Multiple MyelomaRefractory Multiple MyelomaRelapse Multiple Myeloma
Memorial Sloan Kettering Cancer Center 15
Not applicableStudy completedNCT01626547
What this trial is testing

Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology

Who this might be right for
Chemotherapy-induced Symptomatic AnaemiaSolid TumoursMalignant Lymphomas+1 more
Hospira, now a wholly owned subsidiary of Pfizer 291
Early research (Phase 1)Ended earlyNCT00775502
What this trial is testing

Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma

Who this might be right for
Multiple Myeloma
Kyowa Kirin Co., Ltd. 23
Large-scale testing (Phase 3)Active Not RecruitingNCT05455320
What this trial is testing

A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 864
Early research (Phase 1)WithdrawnNCT07082270
What this trial is testing

Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Roswell Park Cancer Institute
Not applicableUnknownNCT03844542
What this trial is testing

Therapeutic Plasma Exchange in the Treatment of Sepsis Associated Multi-Organ Failure [SAMOF-TPE]

Who this might be right for
Sepsis
Forsyth Medical Center 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT04883242
What this trial is testing

Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
University of Washington 30
Testing effectiveness (Phase 2)UnknownNCT05025956
What this trial is testing

Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan

Who this might be right for
Femoroacetabular Impingement
Steadman Philippon Research Institute 68
Early research (Phase 1)UnknownNCT04861480
What this trial is testing

Dual-target CAR-T Cells (C-4-29) in the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Chongqing Precision Biotech Co., Ltd 18
Post-approval studies (Phase 4)Study completedNCT02008331
What this trial is testing

Effect of the Synbiotic Probinul-Neutro® on Gastrointestinal Symptoms and Plasma p-Cresol Level in Chronic Renal Failure

Who this might be right for
Chronic Kidney Disease
Federico II University 30
Large-scale testing (Phase 3)Study completedNCT01296503
What this trial is testing

Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Grupo de Estudos Multicentricos em Onco-Hematologia 213
Next Page